Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Int J Obes (Lond) ; 44(12): 2430-2435, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-32546858

RESUMEN

There are several different methods available for the determination of body fat composition. Two current methods requiring special instrumentation are magnetic resonance imaging (MRI) and dual energy x-ray absorptiometry (DXA). The use of these techniques is very limited despite desirable properties, due to their high costs. Dissection of all fat depots (DF) requires no special instrumentation and allows examination and evaluation of each fat depot in more detail. MRI, DXA, and DF each have their unique advantages and disadvantages when they are applied to animal models. Most studies have determined body fat in young animals, and few studies have been performed in aging models. The aim of this study was to compare MRI, DXA, and DF data in offspring (F1) of mothers fed with control and high-fat diet. We studied rats that varied by age, sex, and maternal diet. The relationships between the three methods were determined via linear regression methods (using log-transformed values to accommodate relativity in the relationships), incorporating when useful age, sex, or diet of the animal. We conclude that the three methods are comparable for measuring body fat, but that direct equivalence gets masked by age, sex, and sometimes dietary group. Depending on the equipment available, the budget of the laboratory, and the nature of the research questions, different approaches may often suggest themselves as the best one.


Asunto(s)
Tejido Adiposo/diagnóstico por imagen , Composición Corporal , Absorciometría de Fotón , Animales , Dieta Alta en Grasa , Disección , Femenino , Imagen por Resonancia Magnética , Masculino , Ratas , Ratas Wistar
3.
Front Microbiol ; 9: 2494, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30386323

RESUMEN

Mexico is experiencing an epidemiological and nutritional transition period, and Mexican children are often affected by the double burden of malnutrition, which includes undernutrition (15.3% of children) and obesity (13.6%). The gut microbiome is a complex and metabolically active community of organisms that influences the host phenotype. Although previous studies have shown alterations in the gut microbiota in undernourished children, the affected bacterial communities remain unknown. The present study investigated and compared the bacterial richness and diversity of the fecal microbiota in groups of undernourished (n = 12), obese (n = 12), and normal-weight (control) (n = 12) Mexican school-age children. We used next-generation sequencing to analyze the V3-V4 region of the bacterial 16S rRNA gene, and we also investigated whether there were correlations between diet and relevant bacteria. The undernourished and obese groups showed lower bacterial richness and diversity than the normal-weight group. Enterotype 1 correlated positively with dietary fat intake in the obese group and with carbohydrate intake in the undernourished group. The results showed that undernourished children had significantly higher levels of bacteria in the Firmicutes phylum and in the Lachnospiraceae family than obese children, while the Proteobacteria phylum was overrepresented in the obese group. The level of Lachnospiraceae correlated negatively with energy consumption and positively with leptin level. This is the first study to examine the gut microbial community structure in undernourished and obese Mexican children living in low-income neighborhoods. Our analysis revealed distinct taxonomic profiles for undernourished and obese children.

4.
Endocrinol. diabetes nutr. (Ed. impr.) ; 64(7): 369-376, ago.-sept. 2017. tab
Artículo en Español | IBECS | ID: ibc-171795

RESUMEN

Antecedentes: La identificación oportuna de niños con síndrome metabólico (SM) es la clave para disminuir el riesgo de desarrollar diabetes y enfermedad cardiovascular en la vida adulta, sin embargo, su detección representa un gran reto debido a las diversas definiciones para su diagnóstico dejando excluidos niños con factores de riesgo a los cuales no se les brindarán medidas preventivas. El objetivo es comparar la prevalencia de SM según las definiciones de la IDF, NCEP-ATP-III, Cook, de Ferranti y Weiss e incluir marcadores de resistencia a la insulina (RI) como el HOMA-IR y/o índice metabólico (IM). Metodología: Estudio transversal en 508 niños mexicanos de 9 a 13 años. Se registraron medidas somatométricas y evaluaron parámetros bioquímicos y hormonales. Resultados: La frecuencia de SM fue de 2,4-45,9% dependiendo de la definición utilizada. La RI en los niños sin diagnóstico de SM fue del 12,4-25,2% con HOMA-IR y 4,0-16,3% con IM. Al incluir el HOMA-IR o IM en cada una de las definiciones la frecuencia de SM fue 8,5-50,2% y 7,7-46,9% respectivamente. El valor de Kappa incluyendo HOMA-IR e IM fue mayor a 0,8. Conclusiones: Este trabajo revela la poca efectividad de las definiciones diagnósticas de SM empleadas actualmente, evidenciada por la variabilidad entre ellas y por la presencia de RI en niños que escapan al diagnóstico de SM. Incluir al HOMA-IR y/o IM en las definiciones, disminuye la probabilidad de excluir niños con SM y aumenta la concordancia entre ellas haciendo posible la comparación de la prevalencia de SM entre las poblaciones (AU)


Background: Early identification of children with metabolic syndrome (MS) is essential to decrease the risk of developing diabetes and cardiovascular disease in adulthood. Detection of MS is however challenging because of the different definitions for diagnosis; as a result, preventive actions are not taken in some children at risk. The study objective was therefore to compare prevalence of MS in children according to the IDF, NCEP-ATP-III, Cook, de Ferranti and Weiss definitions, considering insulin resistance (IR) markers such as HOMA-IR and/or metabolic index (MI). Methods: A total of 508 Mexican children (aged 9 to 13 years) from seven schools were enrolled in a cross-sectional study. Somatometric, biochemical, and hormonal measurements were evaluated. Results: Frequency of MS was 2.4-45.9% depending on the definition used. Frequency of IR in children not diagnosed with MS was 12.4-25.2% using HOMA-IR and 4.0-16.3% using MI. When HOMA-IR or MI was included in each of the definitions, frequency of MS was 8.5-50.2% and 7.7-46.9% respectively. The kappa value including HOMA-IR and/or MI was greater than 0.8. Conclusions: This study demonstrated the poor effectiveness of the current criteria used to diagnose MS in Mexican children, as shown by the variability in the definitions and by the presence of IR in children who not diagnosed with MS. Inclusion of HOMA-IR and/or MI in definitions of MS (thus increasing agreement between them) decreases the chance of excluding children at risk and allows for MS prevalence between populations (AU)


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adolescente , Síndrome Metabólico/diagnóstico , Síndrome Metabólico/epidemiología , Factores de Riesgo , Resistencia a la Insulina , Estudios Transversales , México/epidemiología
5.
Endocrinol Diabetes Nutr ; 64(7): 369-376, 2017.
Artículo en Inglés, Español | MEDLINE | ID: mdl-28745608

RESUMEN

BACKGROUND: Early identification of children with metabolic syndrome (MS) is essential to decrease the risk of developing diabetes and cardiovascular disease in adulthood. Detection of MS is however challenging because of the different definitions for diagnosis; as a result, preventive actions are not taken in some children at risk. The study objective was therefore to compare prevalence of MS in children according to the IDF, NCEP-ATP-III, Cook, de Ferranti and Weiss definitions, considering insulin resistance (IR) markers such as HOMA-IR and/or metabolic index (MI). METHODS: A total of 508 Mexican children (aged 9 to 13 years) from seven schools were enrolled in a cross-sectional study. Somatometric, biochemical, and hormonal measurements were evaluated. RESULTS: Frequency of MS was 2.4-45.9% depending on the definition used. Frequency of IR in children not diagnosed with MS was 12.4-25.2% using HOMA-IR and 4.0-16.3% using MI. When HOMA-IR or MI was included in each of the definitions, frequency of MS was 8.5-50.2% and 7.7-46.9% respectively. The kappa value including HOMA-IR and/or MI was greater than 0.8. CONCLUSIONS: This study demonstrated the poor effectiveness of the current criteria used to diagnose MS in Mexican children, as shown by the variability in the definitions and by the presence of IR in children who not diagnosed with MS. Inclusion of HOMA-IR and/or MI in definitions of MS (thus increasing agreement between them) decreases the chance of excluding children at risk and allows for MS prevalence between populations.


Asunto(s)
Síndrome Metabólico/epidemiología , Adolescente , Antropometría , Biomarcadores/sangre , Niño , Estudios Transversales , Errores Diagnósticos , Hormonas/sangre , Humanos , Síndrome Metabólico/diagnóstico , México/epidemiología , Prevalencia , Medición de Riesgo
6.
Pharmacogenomics ; 17(17): 1881-1889, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27790940

RESUMEN

AIM: CYP2C9 is one of the major drug metabolizing enzymes, however, little is known about polymorphisms in CYP2C9 gene and pharmacological implications in Mexican indigenous populations. Thus, frequencies of CYP2C9*2 and CYP2C9*3 alleles were evaluated in indigenous groups located in northwest (Cora), center (Mazahua and Teenek), south (Chatino and Mixteco) and southeast (Chontal and Maya) regions Mexico. MATERIALS & METHODS: Allelic discrimination was performed by real-time PCR. RESULTS: CYP2C9*2 allele was found only in Chontal and Maya groups, despite the low contribution of Caucasian component in these populations. CYP2C9*3 allele was present in all populations except in Mazahua, showing a wide genetic variability in the studied populations. Interestingly, we found significant differences between indigenous groups in CYP2C9*3 allele, even in groups located at the same region and belonging to the same linguistic family. CONCLUSION: These results contribute to laying the pharmacogenetic bases in Mexico, in addition to improving treatment, taking into account the genetic interethnic differences.

7.
Cir Cir ; 82(1): 119-25, 2014.
Artículo en Español | MEDLINE | ID: mdl-25510799

RESUMEN

Minerals are essential nutrients for the body, are of inorganic nature which gives them the characteristic of being resistant to heat, are involved in a lot of chemical reactions in metabolism, regulating electrolyte balance, in maintaining bone, in the process of blood clotting and the transmission of nerve impulses, particularly its role as enzyme cofactors confers a key role in various physiological processes. Glucose homeostasis involves a fine coordination of events where hormonal control by insulin plays a key role. However, the role of minerals like magnesium, zinc, chromium, iron and selenium in the diabetes is less obvious and in some cases may be controversial. This review shows the knowledge of these five elements and their correlation with diabetes.


Los minerales son nutrientes esenciales para el organismo, de naturaleza inorgánica que les confiere, entre otras características, ser resistentes al calor, participan en diversas reacciones químicas del metabolismo en donde regulan el equilibrio hidroelectrolítico, el mantenimiento óseo, en la trasmisión de los impulsos nerviosos, y durante el proceso de coagulación sanguínea, particularmente por su función como cofactores enzimáticos, tienen un papel clave en varios procesos fisiológicos. La homeostasis de la glucosa involucra una fina coordinación de eventos en donde el control hormonal por la insulina tiene un papel primordial. Sin embargo, la función de los minerales, como el magnesio, el zinc, el cromo, el hierro y el selenio en la diabetes es menos evidente y puede ser, en algún caso, controversial. Esta revisión muestra el conocimiento acerca de estos cinco elementos y su correlación con la diabetes.


Asunto(s)
Diabetes Mellitus/metabolismo , Micronutrientes/fisiología , Minerales/metabolismo , Animales , Cromo/deficiencia , Cromo/fisiología , Cromo/uso terapéutico , Diabetes Mellitus Experimental/metabolismo , Glucosa/metabolismo , Homeostasis , Humanos , Resistencia a la Insulina , Hierro/fisiología , Hierro/uso terapéutico , Deficiencias de Hierro , Magnesio/fisiología , Magnesio/uso terapéutico , Deficiencia de Magnesio/complicaciones , Deficiencia de Magnesio/metabolismo , Síndrome Metabólico/metabolismo , Micronutrientes/uso terapéutico , Minerales/uso terapéutico , Estrés Oxidativo , Selenio/deficiencia , Selenio/fisiología , Selenio/uso terapéutico , Zinc/deficiencia , Zinc/fisiología , Zinc/uso terapéutico
8.
Am J Physiol Endocrinol Metab ; 302(11): E1431-9, 2012 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-22436693

RESUMEN

Maternal low-protein diets (LP) impair pancreatic ß-cell development, resulting in later-life failure and susceptibility to type 2 diabetes (T2D). We hypothesized that intrauterine and/or postnatal developmental programming seen in this situation involve altered ß-cell structure and relative time course of expression of genes critical to ß-cell differentiation and growth. Pregnant Wistar rats were fed either control (C) 20% or restricted (R) 6% protein diets during pregnancy (1st letter) and/or lactation (2nd letter) in four groups: CC, RR, RC, and CR. At postnatal days 7 and 21, we measured male offspring ß-cell fraction, mass, proliferation, aggregate number, and size as well as mRNA level for 13 key genes regulating ß-cell development and function in isolated islets. Compared with CC, pre- and postnatal LP (RR) decreased ß-cell fraction, mass, proliferation, aggregate size, and number and increased Hnf1a, Hnf4a, Pdx1, Isl1, Rfx6, and Slc2a2 mRNA levels. LP only in pregnancy (RC) also decreased ß-cell fraction, mass, proliferation, aggregate size, and number and increased Hnf1a, Hnf4a, Pdx1, Rfx6, and Ins mRNA levels. Postnatal LP offspring (CR) showed decreased ß-cell mass but increased ß-cell fraction, aggregate number, and Hnf1a, Hnf4a, Rfx6, and Slc2a2 mRNA levels. We conclude that LP in pregnancy sets the trajectory of postnatal ß-cell growth and differentiation, whereas LP in lactation has smaller effects. We propose that LP promotes differentiation through upregulation of transcription factors that stimulate differentiation at the expense of proliferation. This results in a decreased ß-cell reserve, which can contribute to later-life predisposition to T2D.


Asunto(s)
Diferenciación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Dieta con Restricción de Proteínas , Células Secretoras de Insulina/efectos de los fármacos , Animales , Animales Recién Nacidos , Glucemia/metabolismo , Peso Corporal/efectos de los fármacos , Separación Celular , Dieta , Ingestión de Alimentos/efectos de los fármacos , Femenino , Técnica del Anticuerpo Fluorescente , Regulación de la Expresión Génica/efectos de los fármacos , Inmunohistoquímica , Insulina/sangre , Masculino , Tamaño de los Órganos/efectos de los fármacos , Páncreas/citología , Páncreas/efectos de los fármacos , Páncreas/crecimiento & desarrollo , Embarazo , Ratas , Ratas Wistar , Factores de Transcripción/biosíntesis , Factores de Transcripción/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...